Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD
Clinical trial NCT05572333 · COMPLETED
Trial details
- NCT number
- NCT05572333
- Sponsor
- EpiEndo Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-22
- Primary completion
- 2023-11-24
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.